Tema Heart & Health ETF HRTS

Medalist Rating as of | See Tema ETFs Investment Hub

Morningstar’s Analysis HRTS

Will HRTS outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Tema Heart & Health ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HRTS

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 48.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

11.51 6M
Healthcare

Thermo Fisher Scientific Inc

5.64 3M
Healthcare

UnitedHealth Group Inc

4.67 2M
Healthcare

Merck & Co Inc

4.37 2M
Healthcare

Novo Nordisk AS Class B

4.13 2M
Healthcare

Revolution Medicines Inc Ordinary Shares

3.84 2M
Healthcare

Roche Holding AG ADR

3.82 2M
Healthcare

Johnson & Johnson

3.63 2M
Healthcare

Cytokinetics Inc

3.40 2M
Healthcare

Gilead Sciences Inc

3.28 2M
Healthcare

Sponsor Center